Penn Medicine: Immunotherapy drug pembrolizumab shows promise for mesothelioma patients

PD-1 inhibitor is safe, shrank tumors or stabilized disease in most patientsThe PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of…

Source link


Would you like to get the test?

This entry was posted in Uncategorized. Bookmark the permalink.